Enterprise Financial Services Corp (EFSC)’s Neurocrine Biosciences NBIX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-64	Closed	-$7K	–	1323
2019 Q4	$7K	Hold	64	–	–	﹤0.01%	799
2019 Q3	$6K	Sell	64 -6,000	-99%	-$561K	﹤0.01%	822
2019 Q2	$511K	Hold	6,064	–	–	0.11%	121
2019 Q1	$535K	Buy	6,064 +6,000	+9,375%	+$501K	0.12%	120
2018 Q4	$5K	Hold	64	–	–	﹤0.01%	660
2018 Q3	$8K	Buy	+64	New	+$7.26K	﹤0.01%	644
2017 Q2	–	Sell	-23	Closed	-$1K	–	1006
2017 Q1	$1K	Sell	23 -42	-65%	-$1.8K	﹤0.01%	1022
2016 Q4	$3K	Sell	65 -150	-70%	-$6.79K	﹤0.01%	852
2016 Q3	$11K	Hold	215	–	–	0.01%	545
2016 Q2	$10K	Buy	+215	New	+$9.9K	0.01%	549
2016 Q1	–	Sell	-257	Closed	-$15K	–	1107
2015 Q4	$15K	Hold	257	–	–	0.01%	472
2015 Q3	$10K	Buy	+257	New	+$12.4K	0.01%	541

Other funds holding NBIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s NBIX Position: Q1 2020 in Review

Enterprise Financial Services Corp (EFSC) sold out of Neurocrine Biosciences (NBIX) in Q1 2020, closing a stake of 64 shares — an estimated $7K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in NBIX in Q3 2015 and held it in 12 quarters. The position peaked at $535K in Q1 2019. 369 funds tracked by Wall St. Rank hold NBIX as of Q1 2020.

Enterprise Financial Services Corp (EFSC) reported no remaining Neurocrine Biosciences position as of Q1 2020 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 64 Neurocrine Biosciences shares in Q1 2020, an estimated $7K.
Enterprise Financial Services Corp (EFSC) first reported a position in Neurocrine Biosciences in Q3 2015 and held it in 12 quarters.
Enterprise Financial Services Corp (EFSC)'s Neurocrine Biosciences position peaked at $535K in Q1 2019.
369 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2020.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2020, filed 15 May 2020.